<DOC>
	<DOCNO>NCT01230008</DOCNO>
	<brief_summary>The use Rituximab propose useful avoid use radiotherapy diffuse large B-cell lymphoma bulky disease.We ass efficacy adjuvant radiotherapy patient treat R-CHOP</brief_summary>
	<brief_title>Radiotherapy Primary Mediastinal Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Diagnosis primary mediastinal lymphoma No previous treatment performance status &lt; 2 HIV , Hepatis B C negative Normal : Renal , hepatic , pulmonary cardiac function pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>primary mediastinal lymphoma</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>rituximab</keyword>
</DOC>